Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
Vivos Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Vivos Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Vivos Therapeutics | 8-K: Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Vivos Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | 8-K: Current report
Vivos Therapeutics | DEFA14A: Others
No Data